Canada Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
122 Pages - SKU: BMI5325544
Countries covered: Canada

Canada Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: Canada will continue to attract pharmaceutical companies to launch innovative medicines dueto the hospitable business environment, improving healthcare coverage and broader drug reimbursementlists. The regulatory authority also encourages pharmaceutical companies to invest in research anddevelopment. However, cost containment policies in the public healthcare sector will continue to putpressure on Canada's medicine prices.

Headline Expenditure Projections

Pharmaceuticals: CAD25.6bn (USD24.9bn) in 2013 to CAD25.9bn (USD22.5bn) in 2014; +0.8% inlocal currency terms and -9.7% in US dollar terms. Forecast unchanged from Q314.



More Prescription Drugs reports by Business Monitor International

Japan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Japan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Japanese pharmaceutical market continues to hold strong rewards for innovativepharmaceutical companies. This is driven by the ...
Tanzania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect the continuing depreciation of the Tanzanian shilling to make imports of rawmaterials increasingly expensive for ...
Romania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Romania Pharmaceuticals and Healthcare Report Q1 2015BMI View: Romania's claw back tax is likely to see a revision as domestic companies lobby to push theburden ...
Latvia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Latvia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Market growth forecasts are strong although the country will continue to present a modestopportunity to larger multinational ...
See all reports like this >>

More Canada Prescription Drugs reports

Pharmaceuticals in Canada by MarketLine
Pharmaceuticals in CanadaIntroductionPharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). ...
Canada Pharmaceutical Industry by Aruvian's R'search
Canada Pharmaceutical IndustryThe Canadian pharmaceutical market is the eighth largest in the world, accounting for about two percent of the world market by sales. Canada ...
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022SummaryDuring the forecast period from 2012-2022, the growth of the UC market will be ...
Pharmaceuticals in Canada: ISIC 2423 by Euromonitor International
Pharmaceuticals in Canada: ISIC 2423Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!